C ardiovascular complications caused by atherosclerosis, such as coronary artery disease and stroke, are major health problems in the Western world. Several factors contribute to atherogenesis, but its main causes are elevated levels of low-density lipoprotein (LDL) and low levels of high-density lipoprotein resulting from genetic factors and excessive consumption of dietary fat. The primary characteristics of atherosclerotic lesions are intimal accumulation of cholesterol-rich macrophages and proliferation of smooth muscle cells. [1] [2] [3] In addition, some advanced lesions stimulate proliferation of vasa vasorum that arise from the adventitia and invade into the vessel wall. The increased vascularity around atheromas is hypothesized to provide oxygen and nutrients and conduits for recruitment of inflammatory cells to the expanding vessel wall. However, they can also lead to hemorrhages that make lesions more prone to rupture. [4] [5] [6] Lymphatic vessels are responsible for collecting and transporting protein-rich extravasated fluid from tissues to blood circulation and are required for chylomicron absorption from the intestinal microvillus. In addition, they participate in inflammatory reactions by transporting antigens and inflammatory cells to lymph nodes and sites of inflammation. 7, 8 Vascular endothelial growth factor receptor 3 (VEGFR3) is a receptor for vascular endothelial growth factor (VEGF)-C and VEGF-D and a key mediator of lymphangiogenesis and maintenance of lymphatic endothelium. 9, 10 VEGFR3 is required for normal vascular development, 11 but its postnatal expression is mainly restricted to lymphatic vessels. organs because they secrete, under the control of the basal keratinocyte K14 promoter, a chimeric fusion protein that consists of the ligand-binding portion of VEGFR3 extracellular domain and the fragment crystallizable domain of immunoglobulin γ-chain. 13 Chy mice have impaired lymphangiogenesis attributable to an inactivating point mutation in the VEGFR3 gene. 
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Effects of Western Diet on Blood Lipid Levels in Mice With Dysfunctional Lymphatic Vessels
Weight gain and food consumption were similar between the Chy mice and their wild-type littermates during the 14-week feeding period on a Western diet (data not shown). Dual-energy x-ray absorptiometry analysis demonstrated a modest but significant reduction of fat mass in Chy mice compared with wild-type littermates (11.6±1.1 versus 15.1±0.8 g; P=0.03). Serum cholesterol levels were significantly higher in Chy mice, both on chow and Western diet ( Figure 1A ). However, no significant differences in the triglyceride levels were observed between the mice of the 2 genotypes ( Figure 1B) . The sVEGFR3 mice and their wild-type littermates had similar body weight and food consumption after 14 weeks on Western diet. No significant changes in total cholesterol or triglycerides ( Figure 1C and 1D) levels were observed between the genotypes although a small trend toward higher cholesterol values was apparent in the sVEGFR3 animals. /ApoB 100/100 mice were viable and fertile, and there was no difference in weight gain compared with controls. sVEGFR3 protein was present in blood plasma in detectable amounts (Figure 2A Figure IB in the online-only Data Supplement). To identify differences in high-density lipoprotein functions, in vivo reverse cholesterol transport (RCT) rates were compared between these 2 strains after injection of macrophages labeled with 3 H-cholesterol in the peritoneum. In vivo RCT was similar in both groups ( Figure IC in the online-only Data Supplement). In addition, the effect of impaired lymphatic vessels on glucose metabolism was analyzed with glucose tolerance tests. Both sVEGFR3×LDLR −/− /ApoB 100/100 mice and Chy×LDLR −/− /ApoB 100/100 mice had similar fasting glucose levels compared with controls, and plasma glucose levels returned to basal levels 60 minutes after the glucose injection in all groups ( Figure ID /ApoB 100/100 mice compared with controls ( Figure 4G-4I ). In the old cohort, area within internal elastic lamina was similar between groups. Differences in the lesion sizes can be easily visualized in the en face opened aortas ( Figure 4J and 4K ) and hematoxylin-eosin stained cross sections ( Figure 4L-4N, respectively) . Plaque neovascularization and lymphatic vessels associated with atherosclerotic lesions in the descending aorta were visualized by confocal microscopy after intravenous injection of glucan synthase-like 1 lectin in vivo, followed by in situ staining with antibodies reactive for podoplanin, a marker on lymphatics. CD31 was expressed on both blood vessels and lymphatics, but only blood perfused blood vessels stained positive for glucan synthase-like 1. Lymphatic vessels stained positive for podoplanin and CD31 but excluded hematogenously delivered glucan synthase-like 1 lectin (Figure 6 ). Atherosclerotic regions in the descending aortas from all genotype groups had similar densities of plaque-associated neovascularization (sVEGFR3×LDLR Figure 6D ). Despite their similar or greater extents of atherosclerosis, lymphatic vessels were less abundant in the adventitia around atheromas 
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Discussion
This study showed that 2 different mouse strains with impaired lymphatic vessel function develop increased cholesterol levels and atherosclerosis when bred into an atherosclerotic background. Indeed, lymphatic vessels are not only required for lipid absorption from the intestine, but may have systemic effects on circulating levels of lipoproteins, inflammatory reactions in peripheral tissues, and atherosclerosis. 1, 5 In normal physiological situations, chylomicrons are taken up from intestinal enterocytes into lacteals, small lymphatic vessels in the mesentery, and transported to blood circulation via the thoracic duct. 16 In addition, lymphatic vessels are involved in endogenous lipoprotein metabolism as extravasated lipoproteins are taken back to blood through lymphatic vessels. 17 Peripheral lymph contains all classes of lipoproteins, but concentrations of LDL and very-low-density lipoprotein are significantly lower than in plasma, suggesting that these lipoproteins are cleared before returning to blood. [18] [19] [20] If the function of lymphatic vessels is impaired either in experimental animals 13, 14, 21 or in humans with hereditary conditions or surgical procedures, 22, 23 adipose tissue is expanded and tissues develop lymphedema. Emerging evidence now indicates that lymphatic vessels have roles in lipid transport, RCT, and in modulating adipose tissue, but knowledge of their functions in hypercholesterolemia and atherosclerosis is limited. 24 Both sVEGFR3×LDLR −/− /ApoB 100/100 mice 13 and Chy×LDLR −/− / ApoB 100/100 mice, 14 which have impaired lymphatic function especially in their skin and some developmental lymphatic defects in other parts of the body, developed higher plasma cholesterol on a Western-type high-fat diet compared with controls in the nonatherosclerotic background and atherosclerosis-prone LDLR −/− /ApoB 100/100 background. It should be noted that the lipoprotein profiles of the mice used in this study and in other studies by our group 25 differ from originally published lipoprotein profiles of LDLR −/− /ApoB 100/100 mice. 15 Mice used in this study have clearly a hypercholesterolemic phenotype and higher levels of cholesterol especially in verylow-density lipoprotein-sized particles and lower levels of cholesterol in LDL-sized particles than in the original publication. 15 This difference could be attributable to the natural transgenic drift of the mouse strains, use of the different background strain, or differences in the lipoprotein analysis methods. However, these differences do not explain the main findings of this study because adequate controls have been used throughout the experiments.
Lipid absorption, LDL turnover, and in vivo RCT after intraperitoneal injection of labeled macrophages were not /ApoB 100/100 control mice. Other studies have shown that RCT is reduced when cholesterol-labeled macrophages were injected in the skin of Chy mice or into distal extremities or peripheral tissues where lymphatics were interrupted. 24 It is possible that the RCT rates from intraperitoneal macrophages into plasma were not significantly altered in sVEGFR×LDLR −/− /ApoB 100/100 mice compared with controls because peritoneal lymphatics were not sufficiently impaired by sVEGFR3. In addition, because hyperlipidemia itself has shown to alter lymphatic vessels in hypercholesterolemic apolipoprotein E-deficient mice, 26, 27 dyslipidemic conditions may have affected lymphatic function also in control mice in this study and obviated RCT differences. On the contrary, VEGF-A and VEGF-B can alter genes involved in lipoprotein metabolism and lipid uptake. 25, 28 Such effects have not been reported for VEGF-C, but if present, then sVEGFR3 might have altered cholesterol and lipoprotein metabolism directly. Therefore, future studies, such as analyzing the lipoprotein production from the liver and evaluating the expression of genes related to lipid metabolism, are needed to clarify the mechanisms how the deficient lymphatic vessels affect hypercholesterolemia and atherosclerosis. /ApoB 100/100 mice resembled livers of control mice. Accumulation of fat in the liver may further activate proinflammatory cytokines (eg, tumor necrosis factor-α) and reactive oxygen species that augment vascular inflammation. 30 Recent studies have shown that although Chy mice have normal immune cell transport from the skin to lymph nodes, 31 K14-VEGFR3-immunoglobulin mice have impaired dendritic cell trafficking and B-cell function in the skin and altered systemic T-cell ratios, and 1-year-old K14-VEGFR3-immunoglobulin mice have many signs of autoimmunity. 32 Depletion of regulatory T cells alone can increase plasma cholesterol levels and induce an atherogenic lipoprotein profile. 33 These results indicate that abnormal lymphatic function could have systemic effects on inflammatory cell homing and lipoprotein metabolism that promote atherosclerosis. [1] [2] [3] Although systemic changes in hypercholesterolemia or immune functions may account for the increased atherosclerosis in mice with deficient lymphatic vessels, impaired lymphatic functions in aortic plaques could have exerted a local effect on plaque growth. An important step in atherosclerotic progression is angiogenesis and growth of vasa vasorum. 34 Intravital microscopy studies of atherosclerotic mice have demonstrated that plaque-associated vessels function as more efficient conduits for inflammatory cell recruitment compared with the arterial endothelium overlying atheromas. 35 Angiogenesis is driven by several factors (eg, VEGF) produced as a response to hypoxia and inflammatory stimuli. 36 In addition to arterial and venous microvessels, lymphatic vessels develop in the adventitia of large arteries. [37] [38] [39] Macrophages in human atherosclerotic lesions express lymphangiogenic factors VEGF-C and VEGF-D and their receptor VEGFR3, 40, 41 and lymphatic growth occurs in the human arteries with calcified and fibrous atherosclerotic plaques. 38, 42 In this study, the density of plaque-associated neovascularization imaged en face from the adventitial surface by confocal microscopy remained at similar levels in all mouse strains, but lymphatic vessels were less abundant in vascularized atheromas of either sVEGFR3×LDLR 24 observed absorptive lymphatics in transverse sections of the aortic sinus and descending aorta and noted the lymphatics weaved in and out of adjacent adipose tissue and were not absent in Chy mice. The Chy mice however were not evaluated in the atherosclerotic background. Other differences should be noted compared with this study. First, this study quantified only plaque-associated lymphatics that adhered to the descending aorta, resided within the plaque borders, and did not invade periaortic fat. Lymphatics and plaque neovascularization in the aortic sinus may vary compared with other aortic regions. Second, plaque-associated lymphatics and neovascularization were both examined and were observed in close proximity. Because normal aortas of mice rarely contain CD31 + blood vessels or vasa vasorum in the adventitia, the close proximity of plaque lymphatics and neovascularization to plaques imaged in this study might have been more specific to lymphatics acquired during atherosclerosis. Indeed, absorptive lymphatics residing near the aorta and in periaortic fat may handle interstitial fluid flow through the aortic wall, but this effect likely diminishes as a function of distance from the aorta and is altered by serosal compartments, branch vessels, and anatomic variations throughout the aorta to designate a strict boundary for lymphatics that regulate interstitial fluid flow across and around the aorta. In agreement with other studies, plaque lymphatics were confined to the adventitia layer, but lymphatic vessels did not invade as deeply toward the media compared with plaque neovascularization, which sometimes extends into the intima at sites of attenuated media in more advanced lesions. 43 Similar to lymphatics residing in the peripheral capsule of tumors, the high tissue pressures of the artery wall may compress and impair the development of functional lymphatics in plaques. 24 Finally, this study identified lymphatics associated with advanced atherosclerosis in aortas, whereas the experimental design of aorta RCT studies used aorta transplant models that disrupted periaortic lymphatics and measured clearance of cholesterol when new lymphatics were allowed to form or were blocked with a VEGFR3 inhibitor. 24 The regrowth of aorta lymphatics in the surgical model may be altered by transient hypoxia in the transplanted tissue, acute wounding responses in the surgical site, different blood flow patterns, and changes in interstitial fluid flow in the transplanted arch segment, which could all differ from mechanisms that regulate local lymphatic growth around atherosclerotic plaques. It is also recognized that antagonists of angiogenesis and lymphangiogenesis may have different responses on physiological and pathological vessel growth in different contexts.
This study raises important questions for investigations of the functions of adventitial lymphatics in atherosclerotic and normal blood vessels. In addition to RCT, adventitial plaque lymphatics might provide a route for transporting unretained cholesterol and lipoproteins out of the vessel wall, because lymphatic vessels are thought to be the main carriers of lipoproteins from interstitium to blood circulation. 24, 27 Alternatively, lymphangiogenesis found at sites of inflammation 38, 44, 45 may provide routes for the entry or egress of immune cells and clearance of pathogens. 46 Lymphatic channels in adventitial aortic tertiary lymphoid organs contain Tand B-cell aggregates, regulatory T cells, and nearby high endothelial venules. Together, the lymphatic conduits and immune cell aggregates in the vessel wall likely have complex effects on vascular immune responses that are involved during both progression and regression phases of atherosclerosis. 47 In conclusion, we show a novel association among impaired lymphatic vessels, lipoprotein metabolism, and increased atherogenesis. These results support the emerging view that lymphatic vessels play an important role in regulating lipoprotein metabolism and vascular biology and may provide new options for the treatment of lipid-related diseases.
